Differential Distribution of microRNAs in Breast Cancer Grouped by Clinicopathological Subtypes |
Li, Jian-Yi
(Department of Breast Surgery, Shengjing Hospital of China Medical University)
Jia, Shi (Department of Breast Surgery, Shengjing Hospital of China Medical University) Zhang, Wen-Hai (Department of Breast Surgery, Shengjing Hospital of China Medical University) Zhang, Yang (Department of Breast Surgery, Shengjing Hospital of China Medical University) Kang, Ye (Department of Breast Surgery, Shengjing Hospital of China Medical University) Li, Pi-Song (Department of Breast Surgery, Shengjing Hospital of China Medical University) |
1 | Aihara M, Wheeler TM, Ohori M, et al (1994) Heterogeneity of prostate cancer in radical prostatectomy specimens. Urology, 43, 60-6 DOI ScienceOn |
2 | Balsat C, Blacher S, Signolle N, et al (2011). Whole slide quantification of stromal lymphatic vessel distribution and peritumoral lymphatic vessel density in early invasive cervical cancer: a method description. ISRN Obstet Gynecol, 25, 1-7. |
3 | Caporali A, Emanueli C (2011). MicroRNA regulation in angiogenesis. Vascul Pharmacol, 55, 79-86. DOI ScienceOn |
4 | Cheng C, Fu X, Alves P, et al (2009). mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer. Genome Biol, 10, R90. DOI ScienceOn |
5 | Choudhry H, Catto JW (2011). Epigenetic regulation of microRNA expression in cancer. Methods Mol Biol, 676, 165-84. DOI ScienceOn |
6 | Cortes-Sempere M, Ibanez de Caceres I (2011). microRNAs as novel epigenetic biomarkers for human cancer. Clin Transl Oncol, 13, 357-62 DOI |
7 | Goldhirsch A, Wood WC, Coates AS, et al (2011). Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol, 22, 1736-47. DOI ScienceOn |
8 | Hughes DP (2009). How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize. Cancer Treat Res, 152, 479-96 DOI ScienceOn |
9 | Iorio MV, Ferracin M, Liu CG, et al (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res, 65, 7065-70 DOI ScienceOn |
10 | Juan HF, Huang HC (2007). Bioinformatics: microarray data clustering and functional classification. Methods Mol Biol, 382, 405-16. DOI ScienceOn |
11 | Kitadai Y, Ellis LM, Takahashi Y, et al (1995). Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas. Clin Cancer Res, 1, 1095-102. |
12 | Kreiner T, Buck KT (2005). Moving toward whole-genome analysis: a technology perspective. Am J Health Syst Pharm, 62, 296-305. |
13 | Krishna MC, Matsumoto S, Yasui H, et al (2012). Electron paramagnetic resonance imaging of tumor . Radiat Res, 177, 376-86 DOI |
14 | Li JY, Zhang Y, Zhang WH, et al (2012). Differential distribution of miR-20a and miR-20b may underly metastatic heterogeneity of breast cancers. Asian Pac J Cancer Prev, 13, 1901-6. DOI ScienceOn |
15 | Orlando PA, Gatenby RA, Brown JS (2013). Tumor evolution in space: the effects of competition colonization tradeoffs on tumor invasion dynamics. Front Oncol, 3, 45. |
16 | Pritchard CC, Cheng HH, Tewari M (2012). MicroRNA profiling: approaches and considerations. Nat Rev Genet, 13, 358-69. |
17 | Stransky B, de Souza SJ (2012). Modeling tumor evolutionary dynamics. Front Physiol, 3, 480. |
18 | Teixeira MR, Heim S (2011). Cytogenetic analysis of tumor clonality. Adv Cancer Res, 112, 127-49 DOI ScienceOn |
19 | Wilson DF, Cerniglia GJ (1992). Localization of tumors and evaluation of their state of oxygenation by phosphorescence imaging. Cancer Res, 52, 3988-93. |